AMEREN CORP — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that AMEREN CORP filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $8.80B | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | $7.62B | Feb 18, 2026 |
| FY2025 | Dec 31, 2023 | $7.50B | Feb 18, 2026 |
| FY2024 | Dec 31, 2022 | $7.96B | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | $6.39B | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $5.79B | Feb 22, 2023 |
| FY2021 | Dec 31, 2019 | $5.91B | Feb 23, 2022 |
| FY2018 | Dec 31, 2018 | $1.42B | Feb 26, 2019 |
| FY2018 | Sep 30, 2018 | $1.72B | Feb 26, 2019 |
| FY2018 | Jun 30, 2018 | $1.56B | Feb 26, 2019 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | ($60.00M) | Feb 28, 2018 |
| FY2017 | Sep 30, 2017 | $288.00M | Feb 28, 2018 |
| FY2017 | Jun 30, 2017 | $193.00M | Feb 28, 2018 |
| FY2017 | Mar 31, 2017 | $102.00M | Feb 28, 2018 |
| FY2017 | Dec 31, 2016 | $32.00M | Feb 28, 2018 |
| FY2017 | Sep 30, 2016 | $369.00M | Feb 28, 2018 |
| FY2017 | Jun 30, 2016 | $147.00M | Feb 28, 2018 |
| FY2017 | Mar 31, 2016 | $105.00M | Feb 28, 2018 |
| FY2016 | Dec 31, 2015 | $29.00M | Feb 28, 2017 |
| FY2016 | Sep 30, 2015 | $343.00M | Feb 28, 2017 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.03B | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | $1.52B | Feb 18, 2026 |
| FY2025 | Dec 31, 2023 | $1.56B | Feb 18, 2026 |
| FY2024 | Dec 31, 2022 | $1.52B | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | $1.33B | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $1.30B | Feb 22, 2023 |
| FY2019 | Dec 31, 2019 | $179.00M | Feb 28, 2020 |
| FY2019 | Sep 30, 2019 | $520.00M | Feb 28, 2020 |
| FY2019 | Jun 30, 2019 | $280.00M | Feb 28, 2020 |
| FY2019 | Mar 31, 2019 | $288.00M | Feb 28, 2020 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.35B | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | $2.76B | Feb 18, 2026 |
| FY2025 | Dec 31, 2023 | $2.56B | Feb 18, 2026 |
| FY2024 | Dec 31, 2022 | $2.26B | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | $1.66B | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $1.73B | Feb 22, 2023 |
| FY2021 | Dec 31, 2019 | $2.17B | Feb 23, 2022 |
| FY2020 | Dec 31, 2018 | $2.17B | Feb 22, 2021 |
| FY2019 | Dec 31, 2017 | $2.12B | Feb 28, 2020 |
| FY2018 | Dec 31, 2016 | $2.12B | Feb 26, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.13B | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | $4.32B | Feb 18, 2026 |
| FY2025 | Dec 31, 2023 | $3.60B | Feb 18, 2026 |
| FY2024 | Dec 31, 2022 | $3.35B | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | $3.48B | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $3.23B | Feb 22, 2023 |
| FY2021 | Dec 31, 2019 | $2.41B | Feb 23, 2022 |
| FY2020 | Dec 31, 2018 | $2.29B | Feb 22, 2021 |
| FY2019 | Dec 31, 2017 | $2.13B | Feb 28, 2020 |
| FY2018 | Dec 31, 2016 | $2.08B | Feb 26, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $48.48B | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | $44.60B | Feb 18, 2026 |
| FY2024 | Dec 31, 2023 | $40.83B | Feb 18, 2025 |
| FY2023 | Dec 31, 2022 | $37.90B | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $35.74B | Feb 22, 2023 |
| FY2021 | Dec 31, 2020 | $32.03B | Feb 23, 2022 |
| FY2020 | Dec 31, 2019 | $28.93B | Feb 22, 2021 |
| FY2019 | Dec 31, 2018 | $27.22B | Feb 28, 2020 |
| FY2018 | Dec 31, 2017 | $25.95B | Feb 26, 2019 |
| FY2017 | Dec 31, 2016 | $24.70B | Feb 28, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $13.40B | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | $12.11B | Feb 18, 2026 |
| FY2024 | Dec 31, 2023 | $11.35B | Feb 18, 2025 |
| FY2023 | Dec 31, 2022 | $10.51B | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $9.70B | Feb 22, 2023 |
| FY2021 | Dec 31, 2020 | $8.94B | Feb 23, 2022 |
| FY2020 | Dec 31, 2019 | $8.06B | Feb 22, 2021 |
| FY2019 | Dec 31, 2018 | $7.63B | Feb 28, 2020 |
| FY2018 | Dec 31, 2017 | $7.18B | Feb 26, 2019 |
| FY2017 | Dec 31, 2016 | $7.10B | Feb 28, 2018 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $411.00M | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | $411.00M | Feb 18, 2026 |
| FY2024 | Dec 31, 2023 | $411.00M | Feb 18, 2025 |
| FY2023 | Dec 31, 2022 | $411.00M | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $411.00M | Feb 22, 2023 |
| FY2021 | Dec 31, 2020 | $411.00M | Feb 23, 2022 |
| FY2020 | Dec 31, 2019 | $411.00M | Feb 22, 2021 |
| FY2019 | Dec 31, 2018 | $411.00M | Feb 28, 2020 |
| FY2018 | Dec 31, 2017 | $411.00M | Feb 26, 2019 |
| FY2017 | Dec 31, 2016 | $411.00M | Feb 28, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.29B | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | $4.60B | Feb 18, 2026 |
| FY2024 | Dec 31, 2023 | $4.14B | Feb 18, 2025 |
| FY2023 | Dec 31, 2022 | $3.65B | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $3.18B | Feb 22, 2023 |
| FY2021 | Dec 31, 2020 | $2.76B | Feb 23, 2022 |
| FY2020 | Dec 31, 2019 | $2.38B | Feb 22, 2021 |
| FY2019 | Dec 31, 2018 | $2.02B | Feb 28, 2020 |
| FY2018 | Dec 31, 2017 | $1.66B | Feb 26, 2019 |
| FY2017 | Dec 31, 2016 | $1.57B | Feb 28, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $13.00M | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | $7.00M | Feb 18, 2026 |
| FY2024 | Dec 31, 2023 | $25.00M | Feb 18, 2025 |
| FY2023 | Dec 31, 2022 | $10.00M | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $8.00M | Feb 22, 2023 |
| FY2021 | Dec 31, 2020 | $139.00M | Feb 23, 2022 |
| FY2020 | Dec 31, 2019 | $16.00M | Feb 22, 2021 |
| FY2019 | Dec 31, 2018 | $16.00M | Feb 28, 2020 |
| FY2018 | Dec 31, 2017 | $10.00M | Feb 26, 2019 |
| FY2017 | Dec 31, 2016 | $9.00M | Feb 28, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $19.43B | Feb 18, 2026 |
| FY2024 | Dec 31, 2024 | $17.80B | Feb 18, 2025 |
| FY2023 | Dec 31, 2023 | $16.11B | Feb 29, 2024 |
| FY2022 | Dec 31, 2022 | $14.15B | Feb 22, 2023 |
| FY2021 | Dec 31, 2021 | $13.18B | Feb 23, 2022 |
| FY2020 | Dec 31, 2020 | $11.19B | Feb 22, 2021 |
| FY2019 | Dec 31, 2019 | $9.44B | Feb 28, 2020 |
| FY2018 | Dec 31, 2018 | $8.51B | Feb 26, 2019 |
| FY2017 | Dec 31, 2017 | $8.00B | Feb 28, 2018 |
| FY2016 | Dec 31, 2016 | $7.33B | Feb 28, 2017 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 5 | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | 4 | Feb 18, 2026 |
| FY2025 | Dec 31, 2023 | 4 | Feb 18, 2026 |
| FY2024 | Dec 31, 2022 | 4 | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | 3 | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | 3 | Feb 22, 2023 |
| FY2019 | Dec 31, 2019 | 0 | Feb 28, 2020 |
| FY2019 | Sep 30, 2019 | 1 | Feb 28, 2020 |
| FY2019 | Jun 30, 2019 | 0 | Feb 28, 2020 |
| FY2019 | Mar 31, 2019 | 0 | Feb 28, 2020 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 5 | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | 4 | Feb 18, 2026 |
| FY2025 | Dec 31, 2023 | 4 | Feb 18, 2026 |
| FY2024 | Dec 31, 2022 | 4 | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | 3 | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | 3 | Feb 22, 2023 |
| FY2019 | Dec 31, 2019 | 0 | Feb 28, 2020 |
| FY2019 | Sep 30, 2019 | 1 | Feb 28, 2020 |
| FY2019 | Jun 30, 2019 | 0 | Feb 28, 2020 |
| FY2019 | Mar 31, 2019 | 0 | Feb 28, 2020 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 276.40M | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | 269.90M | Feb 18, 2026 |
| FY2025 | Dec 31, 2023 | 266.30M | Feb 18, 2026 |
| FY2025 | Dec 31, 2022 | 262.00M | Feb 18, 2026 |
| FY2024 | Dec 31, 2021 | 257.70M | Feb 18, 2025 |
| FY2023 | Dec 31, 2020 | 253.30M | Feb 29, 2024 |
| FY2022 | Dec 31, 2019 | 246.20M | Feb 22, 2023 |
| FY2021 | Dec 31, 2018 | 244.50M | Feb 23, 2022 |
| FY2020 | Dec 31, 2017 | 242.60M | Feb 22, 2021 |
| FY2019 | Dec 31, 2016 | 242.60M | Feb 28, 2020 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $768.00M | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | $714.00M | Feb 18, 2026 |
| FY2025 | Dec 31, 2023 | $662.00M | Feb 18, 2026 |
| FY2024 | Dec 31, 2022 | $610.00M | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | $565.00M | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $494.00M | Feb 22, 2023 |
| FY2021 | Dec 31, 2019 | $472.00M | Feb 23, 2022 |
| FY2020 | Dec 31, 2018 | $451.00M | Feb 22, 2021 |
| FY2019 | Dec 31, 2017 | $431.00M | Feb 28, 2020 |
| FY2018 | Dec 31, 2016 | $416.00M | Feb 26, 2019 |